Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CVAC - CureVac partners with myNEO to support development of mRNA immunotherapies

CVAC - CureVac partners with myNEO to support development of mRNA immunotherapies

CureVac N.V.
CureVac (NASDAQ:CVAC) has partnered with myNEO to identify specific antigens found on the surface of tumors that can lead to the development of mRNA immunotherapies. Under an agreement, myNEO will use its biological datasets,  machine learning, and bioinformatics platform to identify and validate specific antigen targets believed to elicit a strong immune response. Financial terms were not disclosed. Seeking Alpha's Quant Rating views CureVac (CVAC) as a hold.

For further details see:

CureVac partners with myNEO to support development of mRNA immunotherapies
Stock Information
Company Name: CureVac N.V.
Stock Symbol: CVAC
Market: NASDAQ
Website: curevac.com
Menu
CVAC CVAC Quote CVAC Short CVAC News CVAC Articles CVAC Message Board
Get CVAC Alerts

News, Short Squeeze, Breakout and More Instantly...